Biblioteca Humberto Rosselli Quijano
Información del autor
Autor Charles M. Beasley |
Documentos disponibles escritos por este autor (2)
Refinar búsqueda
A double-blind, randomized, placebo-controlled trial of olanzapine in the prevention of psychotic relapse / Charles M. Beasley en Journal of Clinical Psychopharmacology, Año 2003 - Vol. 23 - No. 6 (Diciembre)
[artículo]
Título : A double-blind, randomized, placebo-controlled trial of olanzapine in the prevention of psychotic relapse Tipo de documento: texto impreso Autores: Charles M. Beasley, Autor ; Virginia K. Sutton, Autor ; Susan H. Hamilton, Autor Fecha de publicación: 2023 Artículo en la página: pp. 582-594 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Benzodiacepinas, Trastornos psicóticos, Esquizofrenia. Resumen: Sustained response to antipsychotic therapy is an important outcome measure for patients with psychotic disorders. Placebo control in studies of relapse prevention contributes valuable information yet provokes much debate. This study, using placebo as a control, evaluated olanzapine’s efficacy in preventing a psychotic relapse. Link: ./index.php?lvl=notice_display&id=30990
in Journal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 6 (Diciembre) . - pp. 582-594[artículo] A double-blind, randomized, placebo-controlled trial of olanzapine in the prevention of psychotic relapse [texto impreso] / Charles M. Beasley, Autor ; Virginia K. Sutton, Autor ; Susan H. Hamilton, Autor . - 2023 . - pp. 582-594.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 6 (Diciembre) . - pp. 582-594
Palabras clave: Antipsicóticos, Benzodiacepinas, Trastornos psicóticos, Esquizofrenia. Resumen: Sustained response to antipsychotic therapy is an important outcome measure for patients with psychotic disorders. Placebo control in studies of relapse prevention contributes valuable information yet provokes much debate. This study, using placebo as a control, evaluated olanzapine’s efficacy in preventing a psychotic relapse. Link: ./index.php?lvl=notice_display&id=30990 Hematologic reference ranges in a population of patients with schizophrenia / Simon N. Voss en Journal of Clinical Psychopharmacology, Año 2000 - Vol. 20 - No. 6 (Diciembre)
[artículo]
Título : Hematologic reference ranges in a population of patients with schizophrenia Tipo de documento: texto impreso Autores: Simon N. Voss, Autor ; Todd Sanger, Autor ; Charles M. Beasley, Autor Fecha de publicación: 2023 Artículo en la página: pp. 653-657 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Negros afroamericanos, Pruebas - hematológia, Leucocitos, Olanzapina, Pirenzepina, Esquizofrenia. Resumen: The potential hematotoxic effects of antipsychotic drugs are well known and may limit the use of some effective therapies. Although some previous studies have suggested that patients with schizophrenia may have altered "normal" values, only limited data were available. It is now believed that biological values do not usually follow a normal distribution; therefore, reference ranges are frequently used when interpreting laboratory tests in clinical practice and in research. Link: ./index.php?lvl=notice_display&id=31156
in Journal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 6 (Diciembre) . - pp. 653-657[artículo] Hematologic reference ranges in a population of patients with schizophrenia [texto impreso] / Simon N. Voss, Autor ; Todd Sanger, Autor ; Charles M. Beasley, Autor . - 2023 . - pp. 653-657.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 6 (Diciembre) . - pp. 653-657
Palabras clave: Antipsicóticos, Negros afroamericanos, Pruebas - hematológia, Leucocitos, Olanzapina, Pirenzepina, Esquizofrenia. Resumen: The potential hematotoxic effects of antipsychotic drugs are well known and may limit the use of some effective therapies. Although some previous studies have suggested that patients with schizophrenia may have altered "normal" values, only limited data were available. It is now believed that biological values do not usually follow a normal distribution; therefore, reference ranges are frequently used when interpreting laboratory tests in clinical practice and in research. Link: ./index.php?lvl=notice_display&id=31156